Reports | Ajinkya Rahane suffers Grade III hamstring injury, to miss England tour
As per Cricbuzz, Ajinkya Rahane has suffered a critical Grade III hamstring injury, which will force him to be sidelined in Team India’s England tour in June-July. Rahane, who is representing Kolkata Knight Riders in Indian Premier League 2022, is set to leave the bio-bubble on Monday evening.
According to the latest development reported by Cricbuzz, Ajinkya Rahane suffered a critical Grade III hamstring injury during Kolkata Knight Riders' (KKR) last IPL 2022 game versus Sunrisers Hyderabad (SRH) on May 14. Rahane was not seen fielding during the match at MCA Stadium in Pune, and now as per BCCI sources, he will be reporting at the National Cricket Academy (NCA) in Bangalore for rehab.
Rahane will leave bio-bubble on Monday evening, and it may take at least four weeks for recovery. That means he is set to miss India's upcoming England tour, scheduled for June-July. Though Shreyas Iyer replaced him in India's last Test assignment against Sri Lanka, Rahane was still in contention to make a comeback.
The former India's Test vice-captain did not have a memorable outing for KKR in IPL 2022. He was used as an opener in seven games, but could only manage to score 133 runs at not such a high strike rate.
The report further suggested that the BCCI selection committee, led by Chetan Sharma, may pick two squads soon. One of them will play against South Africa at home, while the other will travel to England.
"The unavailability of Rahane may not be as much a headache as the cobbling together a squad, rather squads, for the selectors. With South Africa playing at home in a five-match Twenty20 series after the IPL, the Chetan Sharma-led committee is expected to pick two teams - one for the tour of England and another for the home series against South Africa. The situation will be somewhat similar to last summer, when India had one team in England and another in Sri Lanka," the report read.
Get updates! Follow us on
0
0
0
0
0
0
Comments
Sign up or log in to your account to leave comments and reactions
0 Comments